The data from 14 years of the Equine Injury Database found that the most restrictive void claim rule reduced risk the most ...
Turn Biotechnologies, a pioneer in epigenetic reprogramming, announced the acquisition of groundbreaking ARMMs (ARRDC1 Mediated Microvesicles) technology to broadly expand the number of organs, ...